Citations

Institution: Mayo Clinic Clear

Showing 10 of 108152 citations.

Corticosteroid-Induced Paraplegia—A Diagnostic Clue for Spinal Dural Arterial Venous Fistula
O’Keeffe, Derek T. , Kallmes, David F. , Weinshenker, Brian G. , Mikhail, Michael A, Mikhail, Michael Adly , Lanzino, Giuseppe , Weinshenker, Brian G

JAMA Neurology | July 13, 2015 | Volume: 72 | Issue: 7 | Pages: 833

10.1001/jamaneurol.2015.0757 | PMID 26167899 Get It

Orthostatic Hypotension: Mechanisms, Causes, Management
Low, Phillip A. , Tomalia, Victoria A.

Journal of Clinical Neurology | July 13, 2015 | Volume: 11 | Issue: 3 | Pages: 220

10.3988/jcn.2015.11.3.220 | PMID 26174784 Get It

The Distally Based Dorsal Metatarsal Artery Perforator Flap: Vascular Study and Clinical Implications
Alphen, Nick van, Laungani, Alexis, Christner, Jodie A., Lachman, Nirusha , Carlsen, Brian T. , Saint-Cyr, Michel, van Alphen, Nick A, Laungani, Alexis T

Journal of Reconstructive Microsurgery | July 13, 2015 | Volume: 32 | Issue: 04 | Pages: 245-250

10.1055/s-0035-1554936 | PMID 26165886 Get It

Sustained Weight Loss with Vagal Nerve Blockade but Not with Sham: 18-Month Results of the ReCharge Trial
Shikora, Scott A. , Wolfe, Bruce M. , Anvari, Mehran , Gibbons, Robert D. , Ikramuddin, Sayeed , Miller, Christopher J. , Knudson, Mark B., Tweden, Katherine S. , Sarr, Michael G. , Apovian, Caroline M , Sarwer, David B , Billington, Charles J.

Journal of Obesity | July 12, 2015 | Volume: 2015 | Issue: No issue available | Pages: 1-8

10.1155/2015/365604 | PMID 26246907 Get It

Background/Objectives. Vagal block therapy (vBloc) is effective for moderate to severe obesity at one year.Subjects/Methods. The ReCharge trial is a double-blind, randomized controlled clinical trial of 239 participants with body mass index (BMI) of 40 to 45 kg/m or 35 to 40 kg/m with one or more obesity-related conditions. Interventions were implantation of either vBloc or Sham devices and weight management counseling. Mixed models assessed percent excess weight loss (%EWL) and total weight loss (%TWL) in intent-to-treat analyses. At 18 months, 142 (88%) vBloc and 64 (83%) Sham patients remained enrolled in the study.Results. 18-month weight loss was 23% EWL (8.8% TWL) for vBloc and 10% EWL (3.8% TWL) for Sham (P<0.0001). vBloc patients largely maintained 12-month weight loss of 26% EWL (9.7% TWL). Sham regained over 40% of the 17% EWL (6.4% TWL) by 18 months. Most weight regain preceded unblinding. Common adverse events of vBloc through 18 months were heartburn/dyspepsia and abdominal pain; 98% of events were reported as mild or moderate and 79% had resolved.Conclusions. Weight loss with vBloc was sustained through 18 months, while Sham regained weight between 12 and 18 months. vBloc is effective with a low rate of serious complications.
Treatment of Axis Body Fractures
Kepler, Christopher K., Fleischman, Andrew N. , Traynelis, Vincent C. , Patel, Alpesh A. , Dekutoski, Mark B. , Wood, Kirkham B. , Schroeder, Gregory D. , Aarabi, Bizhan , Okonkwo, David O. , Fehlings, Michael G. , Shaffrey, Christopher I. , Kwon, Brian K. , Kepler, Christopher K. , Vaccaro, Alexander R. , Harrop, James Shields , Bransford, Richard Jackson , Arnold, Paul M. , Nassr, Ahmad , Fehlings, Michael G

Clinical Spine Surgery: A Spine Publication | July 11, 2015 | Volume: 30 | Issue: 10 | Pages: 442-456

10.1097/bsd.0000000000000309 | PMID 29176489 Get It

Study Design: Evidence-based systematic review. Objectives: To define the optimal treatment of fractures involving the C2 body, including those with concomitant injuries, based upon a systematic review of the literature. Summary of Background Data: Axis body fractures have customarily been treated nonoperatively, but there are some injuries that may require operative intervention. High-quality literature is sparse and there are few class I or class II studies to guide treatment decisions. Materials and Methods: A literature search was conducted using PubMed (MEDLINE), Cochrane Central Register of Controlled Trials, and Scopus (EMBASE, MEDLINE, COMPENDEX). The quality of literature was rated according to a grading tool developed by the Center for Evidence-based Medicine. Operative and nonoperative treatment of axis body fractures were compared using fracture bony union as the primary outcome measure. As risk factors for nonunion were not consistently reported, cases were analyzed individually. Results: The literature search identified 62 studies, of which 10 were case reports which were excluded from the analysis. A total of 920 patients from 52 studies were included. The overall bony union rate for all axis body fractures was 91%. Although the majority of fractures were treated nonoperatively, there has been an increasing trend toward operative intervention for Benzel type III (transverse) axis body fractures. Nearly 76% of axis body fractures were classified as type III fractures, of which 88% united successfully. Nearly all Benzel type I and type II axis body fractures were successfully treated nonoperatively. The risk factors for nonunion included: a higher degree of subluxation, fracture displacement, comminution, concurrent injuries, delay in treatment, and older age. Conclusions: High rates for fracture union are reported in the literature for axis body fractures with nonoperative treatment. High-quality prospective studies are required to develop consensus as to which C2 body fractures require operative fixation.
Hypertrophic Cardiomyopathy, Athlete’s Heart, or Both
Kebed, Kalie, Bos, J. Martijn , Anavekar, Nandan S., Ackerman, Michael J. , Ommen, Steve R. , Kebed, Kalie Y, Mulvagh, Sharon L. , Bos, Johan M

Circulation: Cardiovascular Imaging | July 11, 2015 | Volume: 8 | Issue: 7 | Pages: No page available

10.1161/circimaging.115.003312 | PMID 26162782 Get It

Intracoronary vs intravenous bivalirudin bolus in ST-elevation myocardial infarction patients treated with primary angioplasty
Lupi, Alessandro , Rognoni, Andrea , Cavallino, Chiara , Secco, Gioel Gabrio , Reale, Danilo, Cossa, G, Rosso, Roberta , Bongo, Angelo Sante, Cortese, Bernardo , Jaffe, Allan S. , Porto, Italo , Angiolillo, Dominick J. , Jaffe, Allan S. , Cortese, Bernardo

European Heart Journal: Acute Cardiovascular Care | July 11, 2015 | Volume: 5 | Issue: 5 | Pages: 487-496

10.1177/2048872615594499 | PMID 26163529 Get It

An Athymic Rat Model for Mandibular Osteoradionecrosis Allowing for Direct Translation of Regenerative Treatments
Jackson, Ryan S. , Voss, Stephen G. , Wilson, Zachary C., Remmes, Nicholas B. , Stalboerger, Paul G., Keeney, Michael, Moore, Eric J. , Janus, Jeffrey R. , Keeney, Michael G.

Otolaryngology–Head and Neck Surgery | July 10, 2015 | Volume: 153 | Issue: 4 | Pages: 526-531

10.1177/0194599815593278 | PMID 26163450 Get It

ObjectiveWe aim to create a model of mandibular osteoradionecrosis in athymic rats. Athymic rats provide an immunosuppressed environment whereby human stem cells and biomaterials can be used to investigate regenerative solutions for osteoradionecrosis, bridging the gap between in vivo testing and clinical application.Study DesignProspective animal study.SettingAcademic otolaryngology department laboratory.Subjects and MethodsAfter Institutional Animal Care and Use Committee approval, 10 athymic nude rats were divided into 2 groups. The experimental group (n = 6) underwent irradiation (20 Gy), while the control group (n = 4) underwent sham irradiation catheter placement only. All 10 rats underwent extraction of the second mandibular molar 7 days later. The rats were sacrificed 28 days after dental extraction, and their mandibles were harvested. The mandibles were examined with histologic analysis and bone volume analysis based on 3‐dimensional micro–computed tomography.ResultsAll 10 rats survived the experiment period. Radiographic and histologic analysis revealed decreased bone formation in the experimental group compared with the control group. Jaw region volume ratio was 0.83 for the experimental group versus 0.97 in the control group (P =. 003). The region‐of‐interest volume ratio was 0.75 in the experimental group and 0.97 in the control group (P =. 005). Histologically, there were increased osteoclasts (P =. 02) and decreased osteoblasts (P =. 001) as well as increased fibrosis in the experimental group versus the control group.ConclusionMandibular osteoradionecrosis can be effectively and reproducibly produced in an athymic rat model. This will allow further research to study regenerative medicine in an athymic rat model.
Histone Deacetylase 3 Is Required for T Cell Maturation
Hsu, Fan‐Chi , Belmonte, Paul , Constans, Megan, Chen, Meibo W., McWilliams, Douglas C., Hiebert, Scott W. , Belmonte, Paul J, Constans, Megan M, Shapiro, Virginia Smith , Belmonte, Paul J

The Journal of Immunology | July 10, 2015 | Volume: 195 | Issue: 4 | Pages: 1578-1590

10.4049/jimmunol.1500435 | PMID 26163592 Get It

Abstract Recent thymic emigrants are newly generated T cells that need to undergo postthymic maturation to gain functional competency and enter the long-lived naive T cell pool. The mechanism of T cell maturation remains incompletely understood. Previously, we demonstrated that the transcriptional repressor NKAP is required for T cell maturation. Because NKAP associates with histone deacetylase 3 (HDAC3), we examined whether HDAC3 is also required for T cell maturation. Although thymic populations are similar in CD4-cre HDAC3 conditional knockout mice compared with wild-type mice, the peripheral numbers of CD4+ and CD8+ T cells are dramatically decreased. In the periphery, the majority of HDAC3-deficient naive T cells are recent thymic emigrants, indicating a block in T cell maturation. CD55 upregulation during T cell maturation is substantially decreased in HDAC3-deficient T cells. Consistent with a block in functional maturation, HDAC3-deficient peripheral T cells have a defect in TNF licensing after TCR/CD28 stimulation. CD4-cre HDAC3 conditional knockout mice do not have a defect in intrathymic migration, thymic egress, T cell survival, or homeostasis. In the periphery, similar to immature NKAP-deficient peripheral T cells, HDAC3-deficient peripheral T cells were bound by IgM and complement proteins, leading to the elimination of these cells. In addition, HDAC3-deficient T cells display decreases in the sialic acid modifications on the cell surface that recruit natural IgM to initiate the classical complement pathway. Therefore, HDAC3 is required for T cell maturation.